Epstein-Barr virus-associated lymphoproliferative disorders

Clinical trials for Epstein-Barr virus-associated lymphoproliferative disorders explained in plain language.

Never miss a new study

Get alerted when new Epstein-Barr virus-associated lymphoproliferative disorders trials appear

Sign up with your email to follow new studies for Epstein-Barr virus-associated lymphoproliferative disorders, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New cell therapy targets EBV-Linked cancers in early trial

Disease control Recruiting now

This early-phase study is testing an experimental cell therapy called EBV-AST for people with Epstein-Barr virus (EBV)-related lymphoproliferative disorders, including certain blood cancers and post-transplant complications. About 18 adults will receive up to 3 infusions of the t…

Matched conditions: EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS

Phase 1/2 • Sponsor: Daihong Liu • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

Epstein-Barr virus-associated lymphoproliferative disorders

Get alerted when new Epstein-Barr virus-associated lymphoproliferative disorders trials appear

New cell therapy targets EBV-Linked cancers in early trial